Home/CureGenetics/Dr. Yuanyuan Xu
DY

Dr. Yuanyuan Xu

Chairman & CEO

CureGenetics

Therapeutic Areas

CureGenetics Pipeline

DrugIndicationPhase
CGC729Relapsed/Refractory Metastatic Clear Cell Renal Cell CarcinomaPhase 1